Analysis of Hematopoietic Cell Transplants Using Plasma-Depleted Cord Blood Products That Are Not Red Blood Cell Reduced Robert Chow, Auayporn Nademanee, Joseph Rosenthal, Chatchada Karanes, Tang-Her Jaing, Michael L. Graham, Elsa Tsukahara, Brian Wang, David Gjertson, Patrick Tan, Stephen Forman, Lawrence D. Petz Biology of Blood and Marrow Transplantation Volume 13, Issue 11, Pages 1346-1357 (November 2007) DOI: 10.1016/j.bbmt.2007.07.012 Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Kaplan-Meier estimates of the probability of neutrophil engraftment. For A, all transplants (top panel); B, remission first transplants (second panel from top) and platelet 20 K engraftment for C, all transplants (third panel from top); and D, remission first transplants (bottom panel). Biology of Blood and Marrow Transplantation 2007 13, 1346-1357DOI: (10.1016/j.bbmt.2007.07.012) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 All patients—Kaplan-Meier estimates of the probability of A, relapse-free survival of all malignant patients (top panel); B, overall survival of all patients (second panel from top); C, relapse-free survival for remission first transplant patients (third panel from top); and D, overall survival for remission first transplant patients (bottom panel). Biology of Blood and Marrow Transplantation 2007 13, 1346-1357DOI: (10.1016/j.bbmt.2007.07.012) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions